[ LogicBio Therapeutics raises $45M in Series B funding ]

LogicBio Therapeutics has raised $45 million in Series B funding.

Founded in 2014, LogicBio Therapeutics  is a biotechnology company that develops gene therapy and genome editing for the treatment of genetic diseases.

The company will use the fresh financing  to advance gene therapies targeting orphan paediatric disorders through clinical trials.

Funding  Series B
Founded  2014
Country  USA
City  Foster City, California
Founder / CEO  Frederic Chereau
Deal Size   $45M
Investors  OrbiMed
 OrbiMed Israel Partners
 SBI Japan-Israel Innovation Fund
 Edmond de Rothschild Investment  Partners
 Arix Bioscience
Previous Investors  /